"Indian companies are resisting to supply material without advance. Their money is stuck," a pharma industry analyst ... the Doklam impasse in 2017, India chose to become 'aatmanirbhar' (self ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

From a humble beginnings in 1980s, Sun Pharma has grown to become one of the largest generic pharmaceutical companies worldwide, ultimately becoming the largest pharmaceutical company in India ...